Quantitative Gene Co-expression test
Why Do I need QGCT® ?
QGCT is a gene‑based cancer test that analyzes the genes in your tumor tissue to understand how your cancer behaves at a molecular level. By looking at the activity and interaction of thousands of genes, it helps your doctors see which treatment strategies your cancer is more likely to respond to.
How It Helps with Treatment Choices
The main purpose of QGCT is to guide treatment decisions using your own tumor’s biology. Based on your gene expression patterns, the test provides insights into:
Treatments your body is more likely to be sensitive to, so they have a better chance of working against your cancer.
Treatments you may be resistant to, which are less likely to help and may cause unnecessary side effects.
This helps your medical team focus on options that are more suitable for you and avoid those that are less likely to work, supporting truly personalized cancer care.
What should I Expect?
QGCT is usually done on tissue collected during a procedure you are already having, such as a biopsy or surgery, so most patients do not need an extra operation just for this test. After analysis in a specialized laboratory, your doctor receives a detailed report and will discuss with you how the findings may influence your treatment plan.
PIONEERING PRECISION CANCER Care
B.Y. Quantitative Medicine Limited (BYQMed) is a Hong Kong-based biotech company founded in 2018, dedicated to revolutionizing precision cancer medicine through cutting-edge artificial intelligence and big data analysis.
QGCT is our main cancer test that looks closely at the genes in your tumor tissue. By understanding the unique genetic features of your cancer, QGCT helps your doctors choose treatments that are more likely to work for you and avoid those that are less likely to help.
Backed by over 40 years of foundational scientific research led by Prof. Benjamin Yung, PhD — former Dean of Research at Chang Gung University and Chair Professor of Biomedical Science at HK PolyU — BYQMed has developed the world’s first Quantitative Gene Co-expression Test (QGCT®).
